|
| Exchange Received Time 05/11/2018 18:01:17 Exchange Disseminated Time 05/11/2018 18:01:22 Time Taken 00:00:05 | | In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, November 5, 2018; had considered and approved the Unaudited Financial Results of the Company for Quarter and half year ended September 30, 2018; along with the Statement of Assets and Liabilities and Limited Review Report issued by M/s. Savla & Associates, Statutory Auditors of the Company; the copies of which are attached hereunder. |
|
|